Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 273 followers
Latest posts
Last updated 7 minutes ago
Boycott launched against American Diabetes Association includes journal
7 minutes ago
Get your daily dose of health and medicine every weekday with STAT’s...
Opinion: I’m a thoracic surgeon in New York City. For many of my patients, Sept. 11 is still not over
about 3 hours ago
Retired New York City police officer John Aris sat in my office...
Opinion: I’m a public health communications consultant. Pro-vaccine advocacy needs more fun
about 3 hours ago
On April 12, 1955, America threw a vaccine party. That morning, Thomas...
STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field
about 3 hours ago
The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made...
STAT+: An AI tool aims to catch harder-to-detect heart attacks in EKGs
about 3 hours ago
A flurry of artificial intelligence algorithms have promised to help identify heart...
STAT+: Right before midterms, Trump dangles $500 refunds for select ACA enrollees
about 16 hours ago
The Trump administration is promising to send $500 refund checks to nearly...
Platinum-based chemotherapy in childhood causes mutations that age the liver
about 18 hours ago
Platinum-based chemotherapy — in particular cisplatin and carboplatin — are a lifeline...
Why two promising heart drugs flopped and what’s next
about 18 hours ago
On this week’s episode of “The Readout LOUD”: The pharma industry invested...
STAT+: The gifts from pharma companies that keep on giving
about 19 hours ago
For years, drugmakers have offered free meals, samples, gifts, and speaking fees...
STAT+: Can AI save rural health care?
about 21 hours ago
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about...
STAT+: FDA expands Bayer lung cancer drug approval
about 22 hours ago
Want to stay on top of the science and politics driving biotech...
STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
about 23 hours ago
Rise and shine, everyone, another busy day is on the way. And...